Environmental regulation of valvulogenesis: Implications for tissue engineering

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 1, 2011, Pages 8-17

  Riem Vis, Paul W ^a   Kluin, Jolanda ^a   Sluijter, Joost P G ^a   van Herwerden, Lex A ^a   Bouten, Carlijn V C ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Aortic valve; Embryology; Tissue engineering; Valve growth and development

Indexed keywords

CULTURE MEDIUM; CYTOLOGY; EMBRYO DEVELOPMENT; HEART VALVE; HUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE CULTURE; TISSUE ENGINEERING;

ANIMALS; AORTIC VALVE; BIOARTIFICIAL ORGANS; BIOPROSTHESIS; FETAL DEVELOPMENT; HEART VALVE PROSTHESIS; HUMANS; PROSTHESIS DESIGN; TISSUE ENGINEERING;

EID: 78651068833     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.05.032     Document Type: Review

References (93)

1. Schoen F.J., Levy R.J. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999, 47:439-465.
2. Hoerstrup S.P., Sodian R., Daebritz S., Wang J., Bacha E.A., Martin D.P., Moran A.M., Guleserian K.J., Sperling J.S., Kaushal S., Vacanti J.P., Schoen F.J., Mayer J.E. Functional living trileaflet heart valves grown in vitro. Circulation 2000, 102:III44-III49.
3. Misfeld M., Sievers H.H. Heart valve macro- and microstructure. Philos Trans R Soc Lond B Biol Sci 2007, 362:1421-1436.
4. Butcher J.T., Markwald R.R. Valvulogenesis: the moving target. Philos Trans R Soc Lond B Biol Sci 2007, 362:1489-1503.
5. Butcher J.T., Simmons C.A., Warnock J.N. Mechanobiology of the aortic heart valve. J Heart Valve Dis 2008, 17:62-73.
6. Schroeder J.A., Jackson L.F., Lee D.C., Camenisch T.D. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 2003, 81:392-403.
7. Chang C.P., Neilson J.R., Bayle J.H., Gestwicki J.E., Kuo A., Stankunas K., Graef I.A., Crabtree G.R. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118:649-663.
8. Nakajima Y., Mironov V., Yamagishi T., Nakamura H., Markwald R.R. Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3. Dev Dyn 1997, 209:296-309.
9. Camenisch T.D., Schroeder J.A., Bradley J., Klewer S.E., McDonald J.A. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 2002, 8:850-855.
10. Mjaatvedt C.H., Yamamura H., Capehart A.A., Turner D., Markwald R.R. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 1998, 202:56-66.
11. O'Rahilly R., Müller F. Human embryology & teratology 2001, Wiley-Liss, Wilmington, DE.
12. Stock U.A., Vacanti J.P. Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng 2001, 7:1-7.
13. Bartman T., Walsh E.C., Wen K.K., McKane M., Ren J., Alexander J., Rubenstein P.A., Stainier D.Y. Early myocardial function affects endocardial cushion development in zebrafish. PLoS Biol 2004, 2:E129.
14. Butcher J.T., McQuinn T.C., Sedmera D., Turner D., Markwald R.R. Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition. Circ Res 2007, 100:1503-1511.
15. Lee Y.M., Cope J.J., Ackermann G.E., Goishi K., Armstrong E.J., Paw B.H., Bischoff J. Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish. Dev Dyn 2006, 235:29-37.
16. Rivera-Feliciano J., Tabin C.J. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev Biol 2006, 295:580-588.
17. Sugi Y., Yamamura H., Okagawa H., Markwald R.R. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev Biol 2004, 269:505-518.
18. Jiao K., Kulessa H., Tompkins K., Zhou Y., Batts L., Baldwin H.S., Hogan B.L. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev 2003, 17:2362-2367.
19. Person A.D., Klewer S.E., Runyan R.B. Cell biology of cardiac cushion development. Int Rev Cytol 2005, 243:287-335.
20. Combs M.D., Yutzey K.E. Heart valve development: regulatory networks in development and disease. Circ Res 2009, 105:408-421.
21. Butcher J.T., Norris R.A., Hoffman S., Mjaatvedt C.H., Markwald R.R. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 2007, 302:256-266.
22. Camenisch T.D., Molin D.G., Person A., Runyan R.B., Gittenberger-de Groot A.C., McDonald J.A., Klewer S.E. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 2002, 248:170-181.
23. Sugi Y., Ito N., Szebenyi G., Myers K., Fallon J.F., Mikawa T., Markwald R.R. Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev Biol 2003, 258:252-263.
24. Iwamoto R., Mekada E. ErbB and HB-EGF signaling in heart development and function. Cell Struct Funct 2006, 31:1-14.
25. Biechler S.V., Potts J.D., Yost M.J., Junor L., Goodwin R.L., Weidner J.W. Mathematical modeling of flow-generated forces in an in vitro system of cardiac valve development. Ann Biomed Eng 2010, 38:109-117.
26. Lincoln J., Alfieri C.M., Yutzey K.E. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn 2004, 230:239-250.
27. Jackson L.F., Qiu T.H., Sunnarborg S.W., Chang A., Zhang C., Patterson C., Lee D.C. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 2003, 22:2704-2716.
28. Inai K., Norris R.A., Hoffman S., Markwald R.R., Sugi Y. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol 2008, 315:383-396.
29. Norris R.A., Moreno-Rodriguez R.A., Sugi Y., Hoffman S., Amos J., Hart M.M., Potts J.D., Goodwin R.L., Markwald R.R. Periostin regulates atrioventricular valve maturation. Dev Biol 2008, 316:200-213.
30. Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., Yutzey K.E. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 2006, 98:1431-1438.
31. Aikawa E., Whittaker P., Farber M., Mendelson K., Padera R.F., Aikawa M., Schoen F.J. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006, 113:1344-1352.
32. Kruithof B.P., Krawitz S.A., Gaussin V. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev Biol 2007, 302:208-217.
33. Rabkin-Aikawa E., Farber M., Aikawa M., Schoen F.J. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis 2004, 13:841-847.
34. Struijk P.C., Mathews V.J., Loupas T., Stewart P.A., Clark E.B., Steegers E.A., Wladimiroff J.W. Blood pressure estimation in the human fetal descending aorta. Ultrasound Obstet Gynecol 2008, 32:673-681.
35. Dasi L.P., Sucosky P., de Z.D., Sundareswaran K., Jimenez J., Yoganathan A.P. Advances in cardiovascular fluid mechanics: bench to bedside. Ann N Y Acad Sci 2009, 1161:1-25.
36. Shelton E.L., Yutzey K.E. Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev Biol 2007, 302:376-388.
37. McCulley D.J., Kang J.O., Martin J.F., Black B.L. BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development. Dev Dyn 2008, 237:3200-3209.
38. Norris R.A., Potts J.D., Yost M.J., Junor L., Brooks T., Tan H., Hoffman S., Hart M.M., Kern M.J., Damon B., Markwald R.R., Goodwin R.L. Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 2009, 238:1052-1063.
39. de Lange F.J., Moorman A.F., Anderson R.H., Manner J., Soufan A.T., de Gier-de V.C., Schneider M.D., Webb S., van den Hoff M.J., Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves. Circ Res 2004, 95:645-654.
40. Mol A., Rutten M.C., Driessen N.J., Bouten C.V., Zund G., Baaijens F.P., Hoerstrup S.P. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation 2006, 114:I152-I158.
41. Schopka S., Schmid F.X., Hirt S., Birnbaum D.E., Schmid C., Lehle K. Recellularization of biological heart valves with human vascular cells: in vitro hemocompatibility assessment. J Biomed Mater Res B Appl Biomater 2009, 88:130-138.
42. Hoffman-Kim D., Maish M.S., Krueger P.M., Lukoff H., Bert A., Hong T., Hopkins R.A. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. Tissue Eng 2005, 11:288-301.
43. Riem Vis P.W., Bouten C.V., Sluijter J.P., Pasterkamp G., van Herwerden L.A., Kluin J. Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering. Tissue Eng Part A 2010, 16:1317-1327.
44. Iop L., Renier V., Naso F., Piccoli M., Bonetti A., Gandaglia A., Pozzobon M., Paolin A., Ortolani F., Marchini M., Spina M., De C.P., Sartore S., Gerosa G. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. Biomaterials 2009, 30:4104-4116.
45. Ramaswamy S., Gottlieb D., Engelmayr G.C., Aikawa E., Schmidt D.E., Gaitan-Leon D.M., Sales V.L., Mayer J.E., Sacks M.S. The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials 2009, 31:1114-1125.
46. Sales V.L., Mettler B.A., Lopez-Ilasaca M., Johnson J.A., Mayer J.E. Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: application of green and red fluorescent protein-expressing retroviral vector. Tissue Eng 2007, 13:525-535.
47. Colazzo F., Sarathchandra P., Chester A.H., Mattie B.A., Yacoub M.H., Taylor P.M. An evaluation of adipose-derived stem cells for heart valve tissue engineering. 5th Biennial joint meeting of the Society for Heart Valve Disease & Heart Valve Society of America Berlin 2009.
48. Vincentelli A., Wautot F., Juthier F., Fouquet O., Corseaux D., Marechaux S., Le T.T., Fabre O., Susen S., Van B.E., Mouquet F., Decoene C., Prat A., Jude B. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?. J Thorac Cardiovasc Surg 2007, 134:424-432.
49. Visconti R.P., Ebihara Y., Larue A.C., Fleming P.A., McQuinn T.C., Masuya M., Minamiguchi H., Markwald R.R., Ogawa M., Drake C.J. An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res 2006, 98:690-696.
50. Dvorin E.L., Wylie-Sears J., Kaushal S., Martin D.P., Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1. Tissue Eng 2003, 9:487-493.
51. Cebotari S., Lichtenberg A., Tudorache I., Hilfiker A., Mertsching H., Leyh R., Breymann T., Kallenbach K., Maniuc L., Batrinac A., Repin O., Maliga O., Ciubotaru A., Haverich A. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006, 114:I132-I137.
52. Sales V.L., Mettler B.A., Engelmayr G.C., Aikawa E., Bischoff J., Martin D.P., Exarhopoulos A., Moses M., Schoen F.J., Sacks M., Mayer J. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A 2009, 16:257-267.
53. Schleicher M., Wendel H.P., Fritze O., Stock U.A. In vivo tissue engineering of heart valves: evolution of a novel concept. Regen Med 2009, 4:613-619.
54. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., Oh B.H., Lee M.M., Park Y.B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
55. Zhang Y., Ingram D.A., Murphy M.P., Saadatzadeh M.R., Mead L.E., Prater D.N., Rehman J. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2009, 296:H1675-H1682.
56. Lie-Venema H., Eralp I., Markwald R.R., Van Den Akker N.M., Wijffels M.C., Kolditz D.P., van der L.A., Schalij M.J., Poelmann R.E., Bogers A.J., Gittenberger-de Groot A.C. Periostin expression by epicardium-derived cells is involved in the development of the atrioventricular valves and fibrous heart skeleton. Differentiation 2008, 76:809-819.
57. Guldner N.W., Jasmund I., Zimmermann H., Heinlein M., Girndt B., Meier V., Fluss F., Rohde D., Gebert A., Sievers H.H. Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering. Circulation 2009, 119:1653-1660.
58. Lichtenberg A., Tudorache I., Cebotari S., Suprunov M., Tudorache G., Goerler H., Park J.K., Hilfiker-Kleiner D., Ringes-Lichtenberg S., Karck M., Brandes G., Hilfiker A., Haverich A. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006, 114:I559-I565.
59. Robinson P.S., Johnson S.L., Evans M.C., Barocas V.H., Tranquillo R.T. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng 2007, 14:83-95.
60. Tkatchenko T.V., Moreno-Rodriguez R.A., Conway S.J., Molkentin J.D., Markwald R.R., Tkatchenko A.V. Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol Genomics 2009, 39:160-168.
61. Gottlieb D., Kunal T., Emani S., Aikawa E., Brown D.W., Powell A.J., Nedder A., Engelmayr G.C., Melero-Martin J.M., Sacks M.S., Mayer J.E. In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg 2010, 139:723-731.
62. Heise R.L., Ivanova J., Parekh A., Sacks M.S. Generating elastin-rich small intestinal submucosa-based smooth muscle constructs utilizing exogenous growth factors and cyclic mechanical stimulation. Tissue Eng Part A 2009, 15:3951-3960.
63. Kothapalli C.R., Taylor P.M., Smolenski R.T., Yacoub M.H., Ramamurthi A. Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A 2009, 15:501-511.
64. Canalis E., Economides A.N., Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 2003, 24:218-235.
65. Hakuno D., Kimura N., Yoshioka M., Fukuda K. Molecular mechanisms underlying the onset of degenerative aortic valve disease. J Mol Med 2009, 87:17-24.
66. Osman L., Yacoub M.H., Latif N., Amrani M., Chester A.H. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 2006, 114:I547-I552.
67. Yang X., Fullerton D.A., Su X., Ao L., Cleveland J.C., Meng X. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J Am Coll Cardiol 2009, 53:491-500.
68. Kretzschmar M., Doody J., Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 1997, 389:618-622.
69. Lavery K., Swain P., Falb D., aoui-Ismaili M.H. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 2008, 283:20948-20958.
70. Cushing M.C., Mariner P.D., Liao J.T., Sims E.A., Anseth K.S. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J 2008, 22:1769-1777.
71. Birk D.M., Barbato J., Mureebe L., Chaer R.A. Current insights on the biology and clinical aspects of VEGF regulation. Vasc Endovascular Surg 2008, 42:517-530.
72. Olivey H.E., Mundell N.A., Austin A.F., Barnett J.V. Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium. Dev Dyn 2006, 235:50-59.
73. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009, 8:235-253.
74. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; Inspection and Enforcement; 2004.
75. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002, 99:8932-8937.
76. Mannello F., Tonti G.A. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold!. Stem Cells 2007, 25:1603-1609.
77. Engelmayr G.C., Sales V.L., Mayer J.E., Sacks M.S. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: implications for engineered heart valve tissues. Biomaterials 2006, 27:6083-6095.
78. Ku C.H., Johnson P.H., Batten P., Sarathchandra P., Chambers R.C., Taylor P.M., Yacoub M.H., Chester A.H. Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res 2006, 71:548-556.
79. Nguyen T.D., Liang R., Woo S.L., Burton S.D., Wu C., Almarza A., Sacks M.S., Abramowitch S. Effects of cell seeding and cyclic stretch on the fiber remodeling in an extracellular matrix-derived bioscaffold. Tissue Eng Part A 2009, 15:957-963.
80. Merryman W.D., Youn I., Lukoff H.D., Krueger P.M., Guilak F., Hopkins R.A., Sacks M.S. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol 2006, 290:H224-H231.
81. Joyce E.M., Liao J., Schoen F.J., Mayer J.E., Sacks M.S. Functional collagen fiber architecture of the pulmonary heart valve cusp. Ann Thorac Surg 2009, 87:1240-1249.
82. Balguid A., Rubbens M.P., Mol A., Bank R.A., Bogers A.J., van Kats J.P., de Mol B.A., Baaijens F.P., Bouten C.V. The role of collagen cross-links in biomechanical behavior of human aortic heart valve leaflets-relevance for tissue engineering. Tissue Eng 2007, 13:1501-1511.
83. Paul R.G., Bailey A.J. Chemical stabilisation of collagen as a biomimetic. ScientificWorldJournal 2003, 3:138-155.
84. Rubbens M.P., Mol A., van Marion M.H., Hanemaaijer R., Bank R.A., Baaijens F.P., Bouten C.V. Straining mode-dependent collagen remodeling in engineered cardiovascular tissue. Tissue Eng Part A 2009, 15:841-849.
85. Weinberg E.J., Mack P.J., Schoen F.J., Garcia-Cardena G., Kaazempur Mofrad M.R. Hemodynamic environments from opposing sides of human aortic valve leaflets evoke distinct endothelial phenotypes in vitro. Cardiovasc Eng 2010, 10:5-11.
86. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E., Cogan T.A., Dodson A., Martorell J., Bellini S., Parnigotto P.P., Dickinson S.C., Hollander A.P., Mantero S., Conconi M.T., Birchall M.A. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372:2023-2030.
87. Yang L., Scott P.G., Giuffre J., Shankowsky H.A., Ghahary A., Tredget E.E. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002, 82:1183-1192.
88. Souders C.A., Bowers S.L., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circ Res 2009, 105:1164-1176.
89. van Mil A., Doevendans P.A., Sluijter J.P. The potential of modulating small RNA activity in vivo. Mini Rev Med Chem 2009, 9:235-248.
90. Bauersachs J., Thum T. MicroRNAs in the broken heart. Eur J Clin Invest 2007, 37:829-833.
91. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A.M., Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
92. Huang J., Zhao L., Xing L., Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010, 28:357-364.
93. Elmen J., Lindow M., Schutz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjarn M., Hansen H.F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E.M., Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.